Developing drugs that enhance or mimic TMEM175 function could thus help stabilize lysosomal pH and membrane potential, reduce the buildup of neurotoxic proteins, and promote autophagic clearance of cellular waste, thus improving lysosomal function in disease conditions such as PD. Here, TMEM175 is linked to Parkinson disease.